Medicus Pharma (Medicus Pharma) Cash-to-Debt : No Debt ⁽¹⁾ (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Medicus Pharma's cash to debt ratio for the quarter that ended in Dec. 2023 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Medicus Pharma could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Medicus Pharma's Cash-to-Debt or its related term are showing as below:

MDPLF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.12 Med: 0.18 Max: No Debt
Current: 0.74

During the past 3 years, Medicus Pharma's highest Cash to Debt Ratio was No Debt. The lowest was 0.12. And the median was 0.18.

MDPLF's Cash-to-Debt is ranked worse than
55.25% of 1048 companies
in the Drug Manufacturers industry
Industry Median: 0.94 vs MDPLF: 0.74

Medicus Pharma Cash-to-Debt Historical Data

The historical data trend for Medicus Pharma's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Medicus Pharma Cash-to-Debt Chart

Medicus Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Cash-to-Debt

0.12

0.18

No Debt

Medicus Pharma Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial				0.18	0.02	0.06	No Debt	No Debt

Competitive Comparison of Medicus Pharma's Cash-to-Debt

For the Drug Manufacturers - General subindustry, Medicus Pharma's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicus Pharma's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicus Pharma's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Medicus Pharma's Cash-to-Debt falls into.

Medicus Pharma Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Medicus Pharma's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Medicus Pharma had no debt ⁽¹⁾.

Medicus Pharma's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Medicus Pharma had no debt ⁽¹⁾.

Medicus Pharma (OTCPK:MDPLF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Medicus Pharma Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicus Pharma (Medicus Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

MDCX:Canada

Address

100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

http://www.medicuspharma.com

Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (Medicus Pharma) Headlines

From GuruFocus

Medicus Pharma Opens the Market

By PRNewswire • 10-26-2023

Medicus Pharma (Medicus Pharma) Cash-to-Debt : No Debt (1) (As of Dec. 2023)